Oura (OURA)
- xyz:OURA
- Pre-IPO perpetual
- 24/7
- Up to 5x
$48.53
-0.07% · 24hMark · · price updates every 30 seconds
- 24h volume
- $149.02K
- 3,071 contracts
- Open interest
- $606.80K
- isolated margin only
- Premium to oracle
- 0.00%
- oracle $48.53 · 30-min book average
- Since listing
- $45.96 to $56.40
- launched at $50 on 23 Sep
- Funding
- 0.0010%/h
- damped to 1% of normal · no signal here
- Last private round
- About $11B
- over $900M raised, Oct 2025
O 48.41 · H 48.62 · L 48.38 · C 48.38
Catalyst
Hyperliquid candles, local time
end of the grace period · 1 Dec 2026
Senpi read
Too little trading on xyz:OURA for a read.
Ask Senpi to go deeperWritten by Senpi's engine from Senpi Signals: proven-trader and whale positions, open interest and funding on Hyperliquid. It reads positioning in the contract, not Oura's business. A read describes the tape at its time; it is not a forecast or investment advice.
Ask Senpi about OURA
Opens your Senpi quant with the question filled in.
- Who holds the largest OURA positions and when did they open?
- How does the OURA contract price compare with the $40 to $44 IPO range?
- What happened to the contract after Oura postponed its IPO on 29 September?
- What happens to OURA if Oura doesn't list by 1 December?
Free to open · a Senpi account answers it, on the trial then your plan's credits · funds to run a strategy on it
Catalysts and valuation
Updated 12 Nov 2026
Oct 2025
Series E: over $900M raised at about an $11B valuation, led by Fidelity.
24 Aug 2026
Bloomberg reports Oura seeking up to $3B in a US IPO at a valuation above $16B.
21 Sep 2026
Roadshow opens: 50M shares at $40 to $44, Nasdaq ticker OURA, $15.62B fully diluted. Revenue for the nine months to 30 June: $1.21B, up 74%.
29 Sep 2026
IPO postponed on the day it was due to price; Oura cited uncertainty in the IPO market.
11 Nov 2026
Oura agrees to buy AI primary-care company Counsel Health for $625M in cash, expected to close by the end of 2026, and reports preliminary third-quarter revenue of $533M. IPO plans remain on hold.
1 Dec 2026
End of the grace period: cash settlement at the average traded price if there is no listing.
The September terms implied $15.62B fully diluted at $40 to $44 a share; no new terms have been set since the postponement.
Take the read with you
The same read, refreshed on demand, in the Senpi Companion for Chrome, the app, and your own agent through Connectors.
Data: Hyperliquid and Senpi's engine · prices as of · not investment advice · Senpi is not affiliated with Oura, trade.xyz or Hyperliquid
Trading perpetual futures carries a high risk of loss. Nothing on this page is financial advice.